Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2002
11/13/2002CN1379097A Refractory phosphoglyceromutase 1 gene and its polypeptide coded by it and preparing process
11/13/2002CN1379096A Refractory histidyl-tRNA synthetase gene and its polypeptide coded by it and preparing process
11/13/2002CN1379095A Refractory exopolyphosphatase gene and its polypeptide coded by it and preparing process
11/13/2002CN1379094A Refractory tyrosyl tRNA synthetase gene and its polypeptide coded by it and preparing process
11/13/2002CN1379093A Refractory peptidase E gene and its polypeptide coded by it and preparing process
11/13/2002CN1379092A Human cyclophilin coding sequence and its preparing process and application
11/13/2002CN1379091A Refractory arginine inhibitor gene and its polypeptide coded by it and preparing process
11/13/2002CN1379087A Arrhythmia-resistant scorpion peptide recombined colibacillus and its configuring process
11/13/2002CN1379053A Tree-type high-molecular polyamide-amine compound and its preparing process and application
11/13/2002CN1379041A Cytotoxin T lymphocyte
11/13/2002CN1379039A Control of mutational lethal gene associated with synthesis of arabidopsis' chlorophyll
11/13/2002CN1379038A Specific gene associated with stunt of arabidopsis
11/12/2002US6480791 Parallel methods for genomic analysis
11/12/2002US6479735 Transgenic plants including a transgene consisting of a hybrid nucleic acid sequence, comprising at least one unedited mitochondrial gene fragment from higher plants and process for producing them
11/12/2002US6479734 DNA fragment responsive to low temperatures and a plant transformed with the DNA fragment
11/12/2002US6479732 cDNA of 4-coumarate: coenzyme a ligase and process for modifying lignin in plants
11/12/2002US6479731 Pi-ta gene conferring fungal disease resistance to plants
11/12/2002US6479730 DNA Ligase II orthologue uses thereof
11/12/2002US6479729 Mouse model for ocular neovascularization
11/12/2002US6479655 TNF receptor promoter
11/12/2002US6479654 Forms of the angiogenic factor vascular endothelial cell growth factor: VEGF
11/12/2002US6479653 Compositions and method for regulation of transcription
11/12/2002US6479652 Oligonucleotide mediated nucleic acid recombination
11/12/2002US6479644 Method for purifying and enriching molecules
11/12/2002US6479643 Single chain analogs of the TGF-β superfamily (morphons)
11/12/2002US6479642 Cortistatin: neuropeptides
11/12/2002US6479638 Antibodies that specifically bind DNAX leukocyte associated immunoglobulin-like receptor
11/12/2002US6479636 Extracting the sugarcane to obtai cane pression juice; cleaning pression sugarcane juice to remove particulate matter; adjusting; transmitting through membrane separation system to produce apt fractions
11/12/2002US6479635 Receptor activator of NF-κB
11/12/2002US6479634 IL-B30 proteins
11/12/2002US6479633 Chemokine alpha 2
11/12/2002US6479630 Human purinergic P2U receptor
11/12/2002US6479629 Polypeptide; for use in the generation of disease resistant plants
11/12/2002US6479628 Methods and materials relating to IMPDH and GMP production
11/12/2002US6479626 Poly zinc finger proteins with improved linkers
11/12/2002US6479465 Methods of treating colitis using STAT-4 anti-sense oligonucleotides
11/12/2002US6479464 Polypeptide comprising of the following 29 amino acid composition: 6g's, 2f's, 2l's, 1w, 4r's, 2e's, 2n's, 3k's, 1t, 1s, 1a, 1y, 1m, 1c, and 1i, and additional cationic residues to provide a net number of positive charges of at least 8
11/12/2002US6479459 Cytokine designated lerk-5
11/12/2002US6479301 Methods for fabricating an array for use in multiplexed biochemical analysis
11/12/2002US6479292 Genetic alteration in plants using single-stranded oligodeoxynucleotide vectors
11/12/2002US6479291 Cytoplasmic inhibition of gene expression by viral RNA
11/12/2002US6479290 Chimeric adenoviral vectors
11/12/2002US6479289 Mammalian two-hybrid system
11/12/2002US6479288 Method and apparatus for introducing substances into the cell plasma membrane and/or cytosol
11/12/2002US6479287 Method for transformation of cotton and organogenic regeneration
11/12/2002US6479284 Humanized antibody and uses thereof
11/12/2002US6479281 Infectious pseudotyped lentiviral vectors lacking matrix protein and uses thereof
11/12/2002US6479280 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
11/12/2002US6479279 Episomal vectors and uses thereof
11/12/2002US6479273 Filtration method for separating viruses
11/12/2002US6479271 Genes encoding desulfurization enzymes
11/12/2002US6479270 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
11/12/2002US6479268 7970, a novel ATPase-like molecule and uses thereof
11/12/2002US6479267 FY7 polymerase
11/12/2002US6479266 IKK-α proteins nucleic acids and methods
11/12/2002US6479263 Method for detection of micrometastatic prostate cancer
11/12/2002US6479262 Solid phase enzymatic assembly of polynucleotides
11/12/2002US6479261 Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells
11/12/2002US6479260 Cold-inducible expression vector
11/12/2002US6479259 Human peripheral nerve, tetrodotoxin-resistant sodium channel α-subunit polypeptide
11/12/2002US6479258 Non-stochastic generation of genetic vaccines
11/12/2002US6479257 Method of activating protein and an apparatus therefor
11/12/2002US6479255 Polynucleotides encoding human FRP and fragments thereof
11/12/2002US6479254 Polypeptide for use in treatment of lymphadenopathy, autoimmune disease and graft versus host disease; antitumor agents
11/12/2002US6479253 Serine protease inhibitor nucleic acid molecules and uses thereof
11/12/2002US6479250 Eck receptor ligands
11/12/2002US6479247 Antibody for use in the treatment of cancer and arthritis
11/12/2002US6479245 Monoclonal antibody which is specific for activated coagulation factor VII, and its use
11/12/2002US6479243 Method for generating libraries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
11/12/2002US6479239 Detection and characterization of microorganisms
11/12/2002US6479237 Methods for detecting interaction among several proteins
11/12/2002US6479235 Multiplex amplification of short tandem repeat loci
11/12/2002US6479234 Detection of hypermutable nucleic acid sequence in tissue and body fluids
11/12/2002US6479233 Electrogenerated chemiluminescence labels for analysis and/or referencing
11/12/2002US6479055 Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
11/12/2002US6479051 Oral administration of lactobacillus for the treatment and prevention of urogenital infection
11/12/2002CA2249568C Soybean oil having high oxidative stability
11/12/2002CA2220684C Process for controlling sialylation of proteins produced by mammalian cell culture
11/12/2002CA2204535C Molecules that home to a selected organ or tissue in vivo and methods of identifying same
11/12/2002CA2170515C Nucleotide sequences for novel protein tyrosine phosphatases
11/12/2002CA2169635C Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
11/12/2002CA2091061C Dna fragments coding for a bacteriophage-resistant mechanism
11/12/2002CA2088917C Therapeutic ribozyme compositions
11/12/2002CA2065245C Recombinant negative strand rna virus expression systems and vaccines
11/12/2002CA2062820C Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates
11/12/2002CA2055963C Chimeric fibroblast growth factor
11/12/2002CA2045875C Monoclonal antibodies to mycosphaerella species
11/10/2002CA2382463A1 Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
11/07/2002WO2002088736A2 Prenatal diagnosis method on isolated foetal cell of maternal blood
11/07/2002WO2002088395A1 Method of constructing promoter libraries
11/07/2002WO2002088393A1 Antisense modulation of tumor necrosis factor receptor 2 expression
11/07/2002WO2002088392A1 Antisense modulation of gu protein expression
11/07/2002WO2002088391A1 Antisense modulation of bifunctional apoptosis regulator expression
11/07/2002WO2002088390A1 Method and kit for diagnosing gh deficiency
11/07/2002WO2002088387A2 Amplification process
11/07/2002WO2002088386A2 Nasba-based detection of fungi
11/07/2002WO2002088384A1 Screening method
11/07/2002WO2002088382A2 Method for analysing nucleic acid chains
11/07/2002WO2002088378A2 66784, a novel human potassium channel and uses therefor
11/07/2002WO2002088377A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof